Metastatic Squamous Cell Carcinoma from Lung Adenocarcinoma after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy

অনুরূপ উপাদানগুলি

• The impact of smoking status on radiologic tumor progression patterns and response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations
  অনুযায়ী: Cha, Yoon Ki, অন্যান্য
  প্রকাশিত: (2016)
• Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors
  অনুযায়ী: Sim, Jongmin, অন্যান্য
  প্রকাশিত: (2018)
• Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma
  অনুযায়ী: Chang, Yoon Soo, অন্যান্য
  প্রকাশিত: (2016)
• Repeated Favorable Responses to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in a Case of Advanced Lung Adenocarcinoma
  অনুযায়ী: Kim, Eun-Young, অন্যান্য
  প্রকাশিত: (2013)
• Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types
  অনুযায়ী: Park, Sojung, অন্যান্য
  প্রকাশিত: (2021)